Hot Topics
Neuropsychopharmacology (2009) 34, 248–249; doi:10.1038/npp.2008.156
Promise of mGluR2/3 activators in psychiatry
P Jeffrey Conn1 and Carrie K Jones1
1Vanderbilt Program in Drug Discovery, Department of Pharmacology, Vanderbilt Medical Center, Nashville, TN, USA
Correspondence: P Jeffrey Conn, E-mail: jeff.conn@vanderbilt.edu
